Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N7FD
|
||||
Former ID |
DIB003955
|
||||
Drug Name |
Multi-epitope tyrosinase/gp100 vaccine
|
||||
Synonyms |
Melanoma vaccine, Memorial Sloan-Kettering; Multi-epitope tyrosinase/gp100 vaccine (melanoma); Multi-epitope tyrosinase/gp100 vaccine (melanoma), Memorial Sloan-Kettering
|
||||
Drug Type |
Vaccine
|
||||
Indication | Melanoma [ICD9: 172; ICD10:C43] | Phase 2 | [521451] | ||
Company |
Memorial Sloan-Kettering Cancer Center
|
||||
Target and Pathway | |||||
Target(s) | Melanocytes lineage-specific antigen GP100 | Target Info | [521451] | ||
Tyrosine oxidase | Target Info | [521451] | |||
PathWhiz Pathway | Riboflavin Metabolism | ||||
Tyrosine Metabolism | |||||
WikiPathways | Dopamine metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.